Ramipril may increase the hyperkalemic activities of Drospirenone. The risk or severity of adverse effects can be increased when Bortezomib is combined with Ramipril. Ketanserin may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Zomepirac. The serum concentration of Ergotamine can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Clofarabine is combined with Ramipril. The serum concentration of Delavirdine can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Quetiapine. The risk or severity of adverse effects can be increased when Ramipril is combined with Bendroflumethiazide. The risk or severity of adverse effects can be increased when Ramipril is combined with Doxazosin. Ramipril may increase the hypotensive activities of Lercanidipine. The serum concentration of Esmirtazapine can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Nitroglycerin. The risk or severity of adverse effects can be increased when Forasartan is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Pindolol. Avanafil may increase the antihypertensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Pethidine. The risk or severity of adverse effects can be increased when Levosimendan is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Etacrynic acid. The risk or severity of adverse effects can be increased when Ramipril is combined with Dapagliflozin. The risk or severity of adverse effects can be increased when Ramipril is combined with Lumiracoxib. The risk or severity of adverse effects can be increased when Ramipril is combined with Reserpine. Ramipril may increase the hypotensive activities of Niguldipine. The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Ramipril. Tranylcypromine may increase the hypotensive activities of Ramipril. The serum concentration of Midazolam can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Chloroquine. The risk or severity of adverse effects can be increased when Ramipril is combined with Iron Dextran. The risk or severity of adverse effects can be increased when Rotigotine is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Nisoldipine. The risk or severity of adverse effects can be increased when Ramipril is combined with Indomethacin. Ramipril may increase the hypotensive activities of Alprenolol. Ramipril may increase the hypotensive activities of Oxprenolol. Tolvaptan may increase the hyperkalemic activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Tenoxicam. The risk or severity of adverse effects can be increased when Apomorphine is combined with Ramipril. Ramipril may increase the hypotensive activities of Cryptenamine. The risk or severity of adverse effects can be increased when Saxagliptin is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Nebivolol. Enoxaparin may increase the hyperkalemic activities of Ramipril. Nicorandil may increase the hypotensive activities of Ramipril. Rilmenidine may increase the hypotensive activities of Ramipril. Caroxazone may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Balsalazide. The risk or severity of adverse effects can be increased when Ramipril is combined with Indoprofen. Ramipril may increase the hypotensive activities of Latanoprost. The serum concentration of Dienestrol can be decreased when it is combined with Ramipril. The serum concentration of Mestranol can be decreased when it is combined with Ramipril. Methylene blue may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Everolimus is combined with Ramipril. Ramipril may increase the hypotensive activities of Lofexidine. The risk or severity of adverse effects can be increased when Ramipril is combined with Methyldopa. The risk or severity of adverse effects can be increased when Candesartan is combined with Ramipril. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Mefenamic acid. The risk or severity of adverse effects can be increased when Ramipril is combined with Etoricoxib. Ramipril may increase the hypotensive activities of Risperidone. The risk or severity of adverse effects can be increased when Ramipril is combined with Labetalol. Ramipril may increase the arrhythmogenic activities of Ciprofloxacin. Ramipril may increase the hypotensive activities of Tetrahydropalmatine. Iproniazid may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Sevoflurane is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Triamterene. The risk or severity of adverse effects can be increased when Nabilone is combined with Ramipril. Ramipril may increase the hypotensive activities of Dorzolamide. The serum concentration of Imipramine can be increased when it is combined with Ramipril. Ramipril may increase the hypotensive activities of Ticrynafen. Ramipril may increase the hypotensive activities of Deserpidine. The risk or severity of adverse effects can be increased when Ramipril is combined with Levobunolol. The risk or severity of adverse effects can be increased when Ramipril is combined with Azelastine. The serum concentration of Alprazolam can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Zaltoprofen. The risk or severity of adverse effects can be increased when Ramipril is combined with SRT501. The serum concentration of Protriptyline can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Sitagliptin is combined with Ramipril. The serum concentration of Nortriptyline can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Ramipril. The serum concentration of Etravirine can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Rofecoxib. Yohimbine may decrease the antihypertensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Hydrochlorothiazide. The risk or severity of adverse effects can be increased when Ramipril is combined with Torasemide. The serum concentration of Mirtazapine can be increased when it is combined with Ramipril. The serum concentration of Ramipril can be decreased when it is combined with Garlic. The risk or severity of adverse effects can be increased when Ramipril is combined with Nicardipine. Ramipril may increase the hypotensive activities of Celiprolol. The risk or severity of adverse effects can be increased when Ramipril is combined with Indapamide. The risk or severity of adverse effects can be increased when Ramipril is combined with Ibuprofen. Ramipril may increase the hypotensive activities of BQ-123. The serum concentration of Methylergometrine can be increased when it is combined with Ramipril. The serum concentration of Nefazodone can be increased when it is combined with Ramipril. The serum concentration of Lovastatin can be increased when it is combined with Ramipril. The serum concentration of Desipramine can be increased when it is combined with Ramipril. Dihydralazine may increase the hypotensive activities of Ramipril. Ramipril may increase the hypotensive activities of Guanadrel. The risk or severity of adverse effects can be increased when Ramipril is combined with Tolmetin. The risk or severity of adverse effects can be increased when Ramipril is combined with Etofenamate. The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone. The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Ramipril. The risk or severity of adverse effects can be increased when Barnidipine is combined with Ramipril. The metabolism of Verapamil can be decreased when combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Amiloride. The risk or severity of adverse effects can be increased when Ramipril is combined with Acebutolol. The risk or severity of adverse effects can be increased when Ramipril is combined with Flurbiprofen. The risk or severity of adverse effects can be increased when Ramipril is combined with Celecoxib. The risk or severity of adverse effects can be increased when Ramipril is combined with Timolol. The risk or severity of adverse effects can be increased when Ramipril is combined with Nesiritide. The risk or severity of adverse effects can be increased when Ramipril is combined with Cyclophosphamide. The risk or severity of adverse effects can be increased when Ramipril is combined with Leflunomide. The risk or severity of adverse effects can be increased when Ramipril is combined with Salicylamide. Ramipril may increase the hypotensive activities of Phenoxybenzamine. The risk or severity of adverse effects can be increased when Ramipril is combined with Hydralazine. The serum concentration of Estramustine can be decreased when it is combined with Ramipril. Trimethaphan may increase the hypotensive activities of Ramipril. Amobarbital may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Streptokinase is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Curcumin. The serum concentration of Methallenestril can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Parecoxib. The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Carvedilol. Selegiline may increase the hypotensive activities of Ramipril. Acetylsalicylic acid may decrease the antihypertensive activities of Ramipril. Aminosalicylic Acid may decrease the antihypertensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Bromfenac. Ramipril may increase the hypotensive activities of Ambrisentan. The risk or severity of adverse effects can be increased when Ramipril is combined with Methyclothiazide. The serum concentration of Sildenafil can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Bucillamine. Debrisoquin may increase the hypotensive activities of Ramipril.